Starpharma Holdings Limited (ASX:SPL)
Melbourne, May 11, 2009 AEST (ABN Newswire) - The Board of Starpharma Holdings Limited (ASX:SPL)(PINK:SPHRY) has decided to further extend the closing date of the share purchase plan (SPP) due to the Elanco Agreement announcement made today.
Starpharma has already received SPP acceptances in excess of A$1.1 million, with the SPP due to close on Wednesday, 13 May 2009. The SPP will now close at 5.00 pm (AEST) on Friday, 15 May 2009.
The extension is intended to provide eligible shareholders* with the opportunity to consider the Elanco announcement and the significance of this partnership, and in view of the existing closing date, to provide sufficient time to respond.
No action is required to be taken by shareholders who have already made application for shares under the SPP. However if you wish to increase your participation, promptly telephone either Computershare on 1300 507 903 or Starpharma on +61 3 8532 2704.
The other terms of the SPP, including the price of A$0.26 per share and the maximum application value of A$10,000 per shareholder, remain as set out in the offer document mailed to shareholders on 23 April 2009. The revised timetable of key dates for the SPP is now as follows (all times are AEST):
-----------------------------------------------Record Date 7 April 2009Opening Date 23 April 2009Closing Date 15 May 2009Allotment of Shares 22 May 2009Trading of New Sharesexpected to commence on ASX 25 May 2009Holding statements expectedto be dispatched to shareholders 27 May 2009-----------------------------------------------
*As previously advised, Australian and New Zealand registered shareholders who held shares at 7.00 pm (AEST) on the record date of 7 April 2009 are eligible to participate in the Share Purchase Plan.
Contact
Dr Jackie Fairley
Chief Executive Officer
Tel: +61-3-8532-2704
Ben Rogers
Company Secretary
Tel: +61-3-8532-2702
ben.rogers@starpharma.com
| ||
|
